Axogen Inc (NASDAQ: AXGN) flaunted slowness of -3.06% at $32.0, as the Stock market unbolted on Thursday, before settling in for the price of $33.01 at the close. Taking a more long-term approach, AXGN posted a 52-week range of $9.22-$34.71.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 21.24%. Meanwhile, its Annual Earning per share during the time was 21.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 123.84%. This publicly-traded company’s shares outstanding now amounts to $46.12 million, simultaneously with a float of $45.17 million. The organization now has a market capitalization sitting at $1.48 billion.
Axogen Inc (AXGN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Axogen Inc industry. Axogen Inc’s current insider ownership accounts for 2.07%, in contrast to 90.91% institutional ownership. According to the most recent insider trade that took place on Dec 16 ’25, this organization’s Director sold 43,684 shares at the rate of 29.31, making the entire transaction reach 1,280,465 in total value, affecting insider ownership by 93,826. Preceding that transaction, on Dec 16 ’25, Company’s Director sold 46,653 for 29.55, making the whole transaction’s value amount to 1,378,476. This particular insider is now the holder of 0 in total.
Axogen Inc (AXGN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
Axogen Inc’s EPS increase for this current 12-month fiscal period is 123.84% and is forecasted to reach 0.49 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 80.95% through the next 5 years, which can be compared against the 21.24% growth it accomplished over the previous five years trading on the market.
Axogen Inc (NASDAQ: AXGN) Trading Performance Indicators
Let’s observe the current performance indicators for Axogen Inc (AXGN). It’s Quick Ratio in the last reported quarter now stands at 2.64. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.87. Similarly, its price to free cash flow for trailing twelve months is now 441.89.
In the same vein, AXGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.05, a figure that is expected to reach 0.06 in the next quarter, and analysts are predicting that it will be 0.49 at the market close of one year from today.
